Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0001123292-25-000217
Filing Date
2025-05-13
Accepted
2025-05-13 16:15:37
Documents
2
Period of Report
2025-03-31
Effectiveness Date
2025-05-13

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2115
2 informationtable.html INFORMATION TABLE  
2 informationtable.xml INFORMATION TABLE 7794
  Complete submission text file 0001123292-25-000217.txt   11286
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 13F-HR | Act: 34 | File No.: 028-25078 | Film No.: 25940332
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)